Pharmacokinetics and Bioavailability of Haplopine in Mice by Ultra‐High‐Performance Liquid Chromatography–Tandem Mass Spectrometry
Biomedical Chromatography · 2026-12 · 40 (12)
DOI: 10.1002/bmc.70652 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 02.11.2026. Verfasst von Lijiang Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzh…. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Alkaloids. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Haplopine, a furoquinoline alkaloid with documented anti‐inflammatory, antioxidant, and anti‐atopic dermatitis properties, has not yet been characterized with respect to its in vivo disposition. Here, we developed a fast UPLC‐MS/MS assay for quantifying haplopine in mouse blood. Aliquots of 20 μL of blood were subjected to acetonitrile‐based protein precipitation and resolved on a BEH C18 column within a 4‐min run. Quantification was performed in the positive‐ion electrospray multiple reaction monitoring mode, monitoring the transitions m/z 246.2 → 231.3 for haplopine and m/z 326.2 → 291.4 for the internal standard. The method was linear over 1–1000 ng/mL ( r 2 = 0.9998), with intra‐ and inter‐day precision below 13% and 11%, respectively; accuracy ranged from 90.2% to 110.8%, recovery exceeded 87.2%, and matrix effects were 92.8%–99.1%. The validated assay was then applied to study the pharmacokinetics of haplopine in mice following intravenous (2.0 mg/kg) and oral (8 and 16 mg/kg) administration. Absolute oral bioavailability reached 39.1% and 55.0% at 8 and 16 mg/kg, respectively, indicating moderate, dose‐dependent systemic bioavailability. Collectively, these data constitute the first pharmacokinetic description of haplopine and provide a foundation for its continued development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
- Laboratory Animal Center, Wenzhou Medical University, Wenzhou, China.
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Congcong Wen, Xianqin Wang
Zitieren
APA
Zhang, L., Liu, D., Xiang, X., Wu, S., Wen, C., & Wang, X. (2026). Pharmacokinetics and Bioavailability of Haplopine in Mice by Ultra‐High‐Performance Liquid Chromatography–Tandem Mass Spectrometry. Biomedical Chromatography, 40(12). https://doi.org/10.1002/bmc.70652
Vancouver
Zhang L, Liu D, Xiang X, Wu S, Wen C, Wang X. Pharmacokinetics and Bioavailability of Haplopine in Mice by Ultra‐High‐Performance Liquid Chromatography–Tandem Mass Spectrometry. Biomedical Chromatography. 2026;40(12). doi:10.1002/bmc.70652
BibTeX
@article{Zhang2026,
author = {Zhang, Lijiang and Liu, Danyang and Xiang, Xueying and Wu, Suhang and Wen, Congcong and Wang, Xianqin},
title = {Pharmacokinetics and Bioavailability of Haplopine in Mice by Ultra‐High‐Performance Liquid Chromatography–Tandem Mass Spectrometry},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {12},
doi = {10.1002/bmc.70652}
}
EUVIMED